GSK3B and hepatocellular carcinoma: This aligns with the finding that silencing CLU gene transcription decreases the phosphorylation level of AKT and GSK-3β, subsequently inhibiting the proliferation of HCCLM3 cells in hepatocellular carcinoma (HCC) [92].